Oraya Therapeutics’ INTREPID Study Published in Ophthalmology, the official Journal of the American Academy of OphthalmologyApril 18, 2013
The study met primary endpoints, showing that a single dose of Oraya Therapy significantly reduces the need for anti-‐VEGF injections for patients with Wet AMD, with a favorable safety profile one year after administration.
Veracyte Announces That New Study Suggests The Number Of Patients At Risk For Unnecessary Thyroid Surgery Is Likely On The RiseApril 17, 2013
The findings suggest that growing numbers of thyroid nodule patients are also at risk for unnecessary surgery due to ambiguous fine needle aspiration biopsy results, a common problem in thyroid cancer diagnosis.
The University of Pennsylvania Health System and RightCare Solutions, Inc. Announce Expanded Partnership to Reduce ReadmissionsApril 4, 2013
The partnership with RightCare will extend across all Penn hospitals. By leveraging RightCare’s Discharge Decision Support System (D2S2), the health system’s staff will utilize evidence‐based point‐of‐care tools to improve and enhance patient outcomes.